For in vitro laboratory research only. Not for human or veterinary consumption.
India Warehouse ANASTROZOLE — 2.5mg per tablet, 105-count pack. Aromatase inhibitor for postmenopausal hormone receptor-positive breast cancer. In men and bodybuilding: reduces estrogen from aromatization of testosterone and anabolic steroids. Key warning: Contraindicated in premenopausal women without ovarian suppression. Bone density monitoring required. Calcium and vitamin D essential. Do NOT combine with tamoxifen (antagonistic).
Aromatase inhibitor for postmenopausal hormone receptor-positive breast cancer. In men and bodybuilding: reduces estrogen from aromatization of testosterone and anabolic steroids.
How it Works
Non-steroidal competitive inhibitor of aromatase (CYP19A1), reducing conversion of androgens to estrogens by approximately 85% in postmenopausal women.
Quick Specs
Form
Oral tablets — pre-dosed
Active Ingredient
ANASTROZOLE
Dose per Tablet
2.5MG
Pack Size
105 tablets
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)
Common Side Effects
Hot flushes, joint/bone pain (arthralgia — very common), osteoporosis, vaginal dryness, fatigue, headache, increased fracture risk.
Safety Warnings
Contraindicated in premenopausal women without ovarian suppression. Bone density monitoring required. Calcium and vitamin D essential. Do NOT combine with tamoxifen (antagonistic). International shipping: 7–14 days
Research use only
This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.
